• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vivos Therapeutics Inc (NQ: VVOS )

    3.090 +0.250 (+8.80%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 339,238
    Open 2.870
    Bid (Size) 3.160 (1)
    Ask (Size) 3.270 (3)
    Prev. Close 2.840
    Today's Range 2.815 - 3.250
    52wk Range 1.910 - 48.79
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
    Via Investor Brand Network
    Crude Oil Gains Over 1%; Mobileye Global Shares Jump
    Via Benzinga
    Exposures Fossil Fuels

    Performance

    YTD
    -73.81%
    -73.81%
    1 Month
    +34.93%
    +34.93%
    3 Month
    +47.11%
    +47.11%
    6 Month
    +45.41%
    +45.41%
    1 Year
    +6.19%
    +6.19%

    More News

    Read More
    Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today
    Via Benzinga
    TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces $4.3M Registered Direct Offering
    Via Investor Brand Network
    Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000
    Via Benzinga
    Nvidia, T-Mobile US, Vivos Therapeutics, SoFi Technologies, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Via Benzinga
    Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
    Via Benzinga
    Exposures Product Safety
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update
    Via Investor Brand Network
    VVOS Stock Earnings: Vivos Therapeutics Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Plans Release of Q2 2024 Financial Results, Conference Call
    Via Investor Brand Network
    TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot
    Via Investor Brand Network
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Strategic Alliance, Private Equity Investment
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q1 2024 Financial Report, Operational Update
    Via Investor Brand Network
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    VVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q1 2024 Results, Conference Call
    Via Investor Brand Network
    TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discusses Medicare Reimbursement Approval for CARE Oral Medical Devices in Proactive Interview
    Via Investor Brand Network
    Topics Product Recall
    Exposures Legal Product Safety
    TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Achieves Milestone with CARE Oral Medical Devices Gaining Approval for Medicare Reimbursement
    Via Investor Brand Network
    What's Going On With Vivos Therapeutics Stock?
    Via Benzinga
    Why Is Laser Photonics (LASE) Stock Up 130% Today?
    Via InvestorPlace
    Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.